The loss of E-cadherin, an epithelial cell adhesion molecule, has been implicated in metastasis by mediating the epithelial-mesenchymal transition, which promotes invasion and migration of cancer cells. However, recent studies have demonstrated that E-cadherin supports the survival and proliferation of metastatic cancer cells. Here, we identified a metabolic role for E-cadherin in breast cancer by upregulating the de novo serine synthesis pathway (SSP).
View Article and Find Full Text PDFN-adenosine methylation (mA) is the most abundant mRNA modification that controls gene expression through diverse mechanisms. Accordingly, mA-dependent regulation of oncogenes and tumor suppressors contributes to tumor development. However, the role of mA-mediated gene regulation upon drug treatment or resistance is poorly understood.
View Article and Find Full Text PDFThe loss of E-cadherin (E-cad), an epithelial cell adhesion molecule, has been implicated in the epithelial-mesenchymal transition (EMT), promoting invasion and migration of cancer cells and, consequently, metastasis. However, recent studies have demonstrated that E-cad supports the survival and proliferation of metastatic cancer cells, suggesting that our understanding of E-cad in metastasis is far from comprehensive. Here, we report that E-cad upregulates the de novo serine synthesis pathway (SSP) in breast cancer cells.
View Article and Find Full Text PDF